Abstract
Background Phenotypic heterogeneity within autism spectrum disorder (ASD) is compounded by co-occurring psychopathology. Deriving subgroups of individuals with ASD based on co-occurring psychopathology could better our understanding of symptom patterns existing within this population. This study’s goals were to derive subgroups of school-aged children with ASD based on co-occurring psychopathology while controlling for age and sex and to examine correlates of subgroup membership while controlling for ASD symptom severity.
Method Latent class models were estimated with a sample from the Simons Simplex Collection (n = 2,087) using borderline/clinical versus normal range data from five of the DSM-Oriented Scales of the Child Behavior Checklist for Ages 6 to 18 as indicator variables. We evaluated the predictive value of nonverbal IQ (NVIQ) < 70, sleep disturbance, allergies/autoimmune disorders, gastrointestinal disorders, and neurological disorders on subgroup membership using multinomial logistic regression.
Results Four subgroups emerged: “Low Psychopathology” (41.02%), “Externalizing Problems” (12.36%), “Internalizing Problems” (31.58%), and “High Psychopathology” (15.05%). The most significant findings were that NVIQ < 70 was associated with decreased odds of belonging to the “Internalizing Problems” and “High Psychopathology” subgroups over the “Low Psychopathology” subgroup, while sleep disturbance and gastrointestinal disorders were associated with increased odds of belonging to the “Externalizing Problems” and “High Psychopathology” subgroups. Neurological disorders was also associated with increased odds of belonging to the “Externalizing Problems” subgroup.
Conclusion Patterns of psychopathology exist within school-aged children with ASD and are correlated with NVIQ < 70, sleep disturbance, as well as medical conditions, providing guidance for clinical practice and etiology-driven research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
During this secondary data analysis, all relevant ethical guidelines were followed, and any necessary IRB and/or ethics committee approvals were initially obtained by the original data collection sites.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
antonia.piergies{at}ucsf.edu (A. M. H. P.); tomoya.hirota{at}ucsf.edu (T. H.); shuting.zheng{at}ucsf.edu (S. Z.)
monden{at}biostat.med.osaka-u.ac.jp (R. M.)
Data Availability
Approved researchers can obtain the SSC population datasets described in this study by applying at https://base.sfari.org. All the scripts used to run the analyses can be found here: https://osf.io/xyvc2/?view_only=736ea37d02404383bc9125745e3c2391.
https://osf.io/xyvc2/?view_only=736ea37d02404383bc9125745e3c2391
